Concepts (80)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Plaque, Atherosclerotic | 3 | 2023 | 62 | 1.030 |
Why?
|
| Computed Tomography Angiography | 3 | 2023 | 166 | 0.970 |
Why?
|
| Asymptomatic Diseases | 1 | 2023 | 43 | 0.790 |
Why?
|
| Coronary Artery Disease | 3 | 2023 | 395 | 0.770 |
Why?
|
| Predictive Value of Tests | 1 | 2023 | 1819 | 0.570 |
Why?
|
| Severity of Illness Index | 1 | 2023 | 1982 | 0.530 |
Why?
|
| Cranial Nerve Diseases | 1 | 2012 | 9 | 0.380 |
Why?
|
| Ophthalmoplegia | 1 | 2012 | 12 | 0.370 |
Why?
|
| Intracranial Aneurysm | 1 | 2012 | 206 | 0.330 |
Why?
|
| Adipose Tissue, Brown | 2 | 2021 | 96 | 0.320 |
Why?
|
| Embolization, Therapeutic | 1 | 2012 | 279 | 0.300 |
Why?
|
| Endovascular Procedures | 1 | 2012 | 334 | 0.270 |
Why?
|
| Coronary Angiography | 3 | 2023 | 262 | 0.250 |
Why?
|
| Heart | 3 | 2024 | 596 | 0.220 |
Why?
|
| Coronary Vessels | 2 | 2023 | 200 | 0.210 |
Why?
|
| Aortography | 1 | 2023 | 67 | 0.200 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2021 | 3642 | 0.190 |
Why?
|
| Positron Emission Tomography Computed Tomography | 2 | 2021 | 105 | 0.190 |
Why?
|
| Radiopharmaceuticals | 2 | 2021 | 207 | 0.180 |
Why?
|
| Aorta | 1 | 2023 | 294 | 0.180 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2021 | 12 | 0.170 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2021 | 27 | 0.170 |
Why?
|
| Adipose Tissue, White | 1 | 2021 | 28 | 0.170 |
Why?
|
| Health Status Disparities | 1 | 2023 | 221 | 0.160 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase RIalpha Subunit | 1 | 2020 | 2 | 0.160 |
Why?
|
| Carney Complex | 1 | 2020 | 3 | 0.160 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2023 | 472 | 0.160 |
Why?
|
| Myxoma | 1 | 2020 | 31 | 0.160 |
Why?
|
| Paraganglioma | 1 | 2020 | 16 | 0.160 |
Why?
|
| Sex Factors | 1 | 2023 | 1130 | 0.160 |
Why?
|
| Heart Neoplasms | 1 | 2020 | 65 | 0.150 |
Why?
|
| Pheochromocytoma | 1 | 2020 | 53 | 0.150 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2020 | 86 | 0.150 |
Why?
|
| Numbers Needed To Treat | 1 | 2018 | 1 | 0.140 |
Why?
|
| Automation | 1 | 2019 | 115 | 0.140 |
Why?
|
| Primary Prevention | 1 | 2018 | 87 | 0.130 |
Why?
|
| Cardiovascular Diseases | 1 | 2024 | 778 | 0.130 |
Why?
|
| Adult | 7 | 2024 | 28636 | 0.130 |
Why?
|
| Middle Aged | 7 | 2024 | 28299 | 0.130 |
Why?
|
| Risk Assessment | 1 | 2023 | 2498 | 0.120 |
Why?
|
| Risk Factors | 2 | 2023 | 5992 | 0.110 |
Why?
|
| HIV Infections | 1 | 2024 | 974 | 0.110 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2019 | 631 | 0.110 |
Why?
|
| Aged | 4 | 2023 | 20927 | 0.110 |
Why?
|
| Time Factors | 1 | 2023 | 5593 | 0.110 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 395 | 0.100 |
Why?
|
| Male | 7 | 2023 | 45792 | 0.100 |
Why?
|
| Paralysis | 1 | 2012 | 34 | 0.090 |
Why?
|
| Female | 7 | 2023 | 49980 | 0.090 |
Why?
|
| Neurologic Examination | 1 | 2012 | 130 | 0.090 |
Why?
|
| Humans | 11 | 2024 | 95992 | 0.090 |
Why?
|
| Recovery of Function | 1 | 2012 | 348 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2024 | 4690 | 0.070 |
Why?
|
| Liver | 2 | 2021 | 1231 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2021 | 1319 | 0.060 |
Why?
|
| Diastole | 1 | 2024 | 147 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 3922 | 0.040 |
Why?
|
| Monte Carlo Method | 1 | 2021 | 191 | 0.040 |
Why?
|
| Stress, Mechanical | 1 | 2021 | 261 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2021 | 157 | 0.040 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2021 | 150 | 0.040 |
Why?
|
| Germ Cells | 1 | 2020 | 134 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2012 | 9228 | 0.040 |
Why?
|
| Phantoms, Imaging | 1 | 2021 | 490 | 0.040 |
Why?
|
| Myocardium | 1 | 2021 | 606 | 0.040 |
Why?
|
| Multidetector Computed Tomography | 1 | 2018 | 61 | 0.030 |
Why?
|
| Hypertension, Pulmonary | 1 | 2021 | 383 | 0.030 |
Why?
|
| Young Adult | 2 | 2020 | 7034 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 2042 | 0.030 |
Why?
|
| Survival Rate | 1 | 2020 | 1978 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2020 | 10307 | 0.030 |
Why?
|
| Genotype | 1 | 2020 | 1883 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1962 | 0.030 |
Why?
|
| Phenotype | 1 | 2020 | 2575 | 0.030 |
Why?
|
| Incidence | 1 | 2018 | 1723 | 0.020 |
Why?
|
| Prognosis | 1 | 2020 | 3993 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 2777 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 7224 | 0.020 |
Why?
|
| Adolescent | 1 | 2020 | 9878 | 0.020 |
Why?
|
| United States | 1 | 2018 | 7785 | 0.010 |
Why?
|